Out-of-Pocket Costs of Insulin and Diabetes-Related Supplies Among Patients With Type 1 Diabetes

Katherine Julian; Djibril M. Ba; Guodong Liu; Douglas L. Leslie; Cynthia H. Chuang

doi:10.1016/j.clinthera.2021.05.008

Out-of-Pocket Costs of Insulin and Diabetes-Related Supplies Among Patients With Type 1 Diabetes

Research output: Contribution to journal › Article › peer-review

Abstract

The cost of insulin has increased exponentially since its discovery in the 1920s, but the degree to which this financial burden has been transferred to patients is unknown. The present study is a retrospective analysis using claims data for privately insured patients with type 1 diabetes from 2005 to 2017. We quantify the mean annual out-of-pocket costs for insulin and diabetes-related supplies during the study period. It is imperative for health care professionals to be aware of this cost, and we hope that these findings serve as a call for legislation to cap the rising price of insulin.

Original language	English (US)
Pages (from-to)	1272-1277
Number of pages	6
Journal	Clinical therapeutics
Volume	43
Issue number	7
DOIs	https://doi.org/10.1016/j.clinthera.2021.05.008
State	Published - Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmacology (medical)

Access to Document

10.1016/j.clinthera.2021.05.008

Cite this

@article{81c68130254f48c1ab7f53f5c0281e7f,

title = "Out-of-Pocket Costs of Insulin and Diabetes-Related Supplies Among Patients With Type 1 Diabetes",

abstract = "The cost of insulin has increased exponentially since its discovery in the 1920s, but the degree to which this financial burden has been transferred to patients is unknown. The present study is a retrospective analysis using claims data for privately insured patients with type 1 diabetes from 2005 to 2017. We quantify the mean annual out-of-pocket costs for insulin and diabetes-related supplies during the study period. It is imperative for health care professionals to be aware of this cost, and we hope that these findings serve as a call for legislation to cap the rising price of insulin.",

author = "Katherine Julian and Ba, \{Djibril M.\} and Guodong Liu and Leslie, \{Douglas L.\} and Chuang, \{Cynthia H.\}",

note = "Funding Information: Author contributions are as follows: conceptualization: Katherine Julian and Cynthia H. Chaung; methods: Katherine Julian, Djibril M. Ba, and Cynthia H. Chaung; formal analysis: Djibril M. Ba and Guodong Liu: investigation: Katherine Julian, Djibril M. Ba, Duodong Liu, and Douglas L. Leslie: resources: Djibril M. Ba, Guodong Liu, and Doughlas L. Leslie; data curation: Djibril M. Ba; writing–original draft: Katherine Julian; writing–review and editing: Katherine Julian, Djibril M. Ba, Guodong Liu, Douglas L. Leslie, and Cynthia H. Chuang; and supervision: Cynthia H. Chuang. Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = jul,

doi = "10.1016/j.clinthera.2021.05.008",

language = "English (US)",

volume = "43",

pages = "1272--1277",

journal = "Clinical therapeutics",

issn = "0149-2918",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Out-of-Pocket Costs of Insulin and Diabetes-Related Supplies Among Patients With Type 1 Diabetes

AU - Julian, Katherine

AU - Ba, Djibril M.

AU - Liu, Guodong

AU - Leslie, Douglas L.

AU - Chuang, Cynthia H.

N1 - Funding Information: Author contributions are as follows: conceptualization: Katherine Julian and Cynthia H. Chaung; methods: Katherine Julian, Djibril M. Ba, and Cynthia H. Chaung; formal analysis: Djibril M. Ba and Guodong Liu: investigation: Katherine Julian, Djibril M. Ba, Duodong Liu, and Douglas L. Leslie: resources: Djibril M. Ba, Guodong Liu, and Doughlas L. Leslie; data curation: Djibril M. Ba; writing–original draft: Katherine Julian; writing–review and editing: Katherine Julian, Djibril M. Ba, Guodong Liu, Douglas L. Leslie, and Cynthia H. Chuang; and supervision: Cynthia H. Chuang. Publisher Copyright: © 2021 Elsevier Inc.

PY - 2021/7

Y1 - 2021/7

N2 - The cost of insulin has increased exponentially since its discovery in the 1920s, but the degree to which this financial burden has been transferred to patients is unknown. The present study is a retrospective analysis using claims data for privately insured patients with type 1 diabetes from 2005 to 2017. We quantify the mean annual out-of-pocket costs for insulin and diabetes-related supplies during the study period. It is imperative for health care professionals to be aware of this cost, and we hope that these findings serve as a call for legislation to cap the rising price of insulin.

AB - The cost of insulin has increased exponentially since its discovery in the 1920s, but the degree to which this financial burden has been transferred to patients is unknown. The present study is a retrospective analysis using claims data for privately insured patients with type 1 diabetes from 2005 to 2017. We quantify the mean annual out-of-pocket costs for insulin and diabetes-related supplies during the study period. It is imperative for health care professionals to be aware of this cost, and we hope that these findings serve as a call for legislation to cap the rising price of insulin.

UR - https://www.scopus.com/pages/publications/85108311009

UR - https://www.scopus.com/pages/publications/85108311009#tab=citedBy

U2 - 10.1016/j.clinthera.2021.05.008

DO - 10.1016/j.clinthera.2021.05.008

M3 - Article

C2 - 34162482

AN - SCOPUS:85108311009

SN - 0149-2918

VL - 43

SP - 1272

EP - 1277

JO - Clinical therapeutics

JF - Clinical therapeutics

IS - 7

ER -

Out-of-Pocket Costs of Insulin and Diabetes-Related Supplies Among Patients With Type 1 Diabetes

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this